Jim Simons's position in MaxCyte is currently worth $2.66M. That's 0.00% of their equity portfolio (1702nd largest holding). The first MaxCyte trade was made in Q1 2023. Since then Jim Simons bought shares eight more times and sold shares on five occasions. The investor's estimated purchase price is $3.72M, resulting in a loss of 29%.